Yuan Cai, Parekh Hiral, Allegra Carmen, George Thomas J, Starr Jason S
1Division of Hematology & Oncology, Department of Medicine, University of Florida, 8962 SW 73rd Lane, Gainesville, FL 32608 USA.
2Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL USA.
Cardiooncology. 2019 Sep 6;5:13. doi: 10.1186/s40959-019-0048-3. eCollection 2019.
5-Fluorouracil (5-FU) is an antimetabolite chemotherapy used for a variety of solid tumors. It has the potential to cause a wide spectrum of cardiotoxicity, ranging from asymptomatic electrocardiographic changes to cardiomyopathy and subsequent cardiac failure. Main body of the abstract: We present two descriptive cases of new-onset severe cardiomyopathy induced by 5-FU followed by a review of the literature.
Our case series emphasizes the importance of early recognition of this rare complication and prompt cessation of 5-FU, as cardiac dysfunction in this context is potentially reversible.
5-氟尿嘧啶(5-FU)是一种用于多种实体瘤的抗代谢化疗药物。它有可能导致广泛的心脏毒性,从无症状的心电图改变到心肌病以及随后的心衰。摘要正文:我们报告两例由5-FU引起的新发严重心肌病的描述性病例,并对文献进行综述。
我们的病例系列强调了早期识别这种罕见并发症并及时停用5-FU的重要性,因为在这种情况下心脏功能障碍可能是可逆的。